Sort
64,565 grants matching “drug discovery”
Emory Chemistry-Biology Center in the MLSCN(RMI)
$2,029,936Emory University · U54 · FY2005 · HG
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)
$2,029,935Emory University · U54 · FY2005 · HG
Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease
$2,029,478Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Developmental Therapeutics Program
$2,029,064James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA
Molecular Targets COBRE
$2,028,469Donald M Miller · University Of Louisville · P20 · FY2011 · RR
Northeast Node of the National Drug Abuse Clinical Trials Network
$2,027,951Lisa A Marsch · Dartmouth College · UG1 · FY2022 · DA
Mechanisms of naturally-acquired immunity to malaria
$2,027,646Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,027,385Redford B Williams · Duke University · P01 · FY2020 · HL
Enhancing ATG-dependent Defense Against Pathogens w/Therapeutics Lead CP
$2,026,830Stuart L Schreiber · Washington University · U19 · FY2014 · AI
New Approaches to Dementia Heterogeneity
$2,026,428Bruce L Miller · University Of California, San Francisco · P50 · FY2017 · AG
Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)
$2,026,377Jeanne Rosenthal · Westat, Inc. · U54 · FY2022 · DA
Re-engineering gp120 to include glycan-dependent epitopes
$2,026,178Phillip Berman · University Of California Santa Cruz · R01 · FY2014 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$2,025,978Ohio State University · U01 · FY2003 · AI
DCTD Natural Products Extraction
$2,025,398David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Harvard-wide Program on Antibiotic Resistance
$2,024,695Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2020 · AI
Mitochondrial Targeting Against Radiation Damage
$2,024,600Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2008 · AI
Molecular Targets COBRE
$2,023,789Donald M Miller · University Of Louisville · P20 · FY2012 · GM
Opioid use disorders: UF Pharmacy medications discovery and development
$2,023,489Lance R McMahon · University Of Florida · UG3 · FY2019 · DA
PHARMACEUTICAL RESEARCH CENTER
$2,022,902Florida Agricultural And Mechanical Univ · G12 · FY2005 · RR
MAP4K3 regulation of cellular stress response pathways in health and disease
$2,022,582Albert R La Spada · University Of California-Irvine · RF1 · FY2022 · AG
Development of Haloperoxidase Enzymes for New Applications in Chemical Synthesis
$2,021,315Kyle Francis Biegasiewicz · Emory University · R35 · FY2025 · GM
New Approaches to Dementia Heterogeneity
$2,019,359Bruce L Miller · University Of California, San Francisco · P50 · FY2014 · AG
Role of Pluripotency Factors in Embryonic Stem Cells, Development and Disease
$2,018,502Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT
$2,018,293Cheryl Stoddart · University Of California, San Francisco · N01 · FY2018 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,018,048David S Stephens · Emory University · UM1 · FY2022 · AI